| Literature DB >> 31199864 |
Roosmarijn E C Luiken1, Liese Van Gompel1, Patrick Munk2, Steven Sarrazin3, Philip Joosten3, Alejandro Dorado-García1, Rasmus Borup Hansen4, Berith E Knudsen2, Alex Bossers1,5, Jaap A Wagenaar5,6, Frank M Aarestrup2, Jeroen Dewulf3, Dik J Mevius5,6, Dick J J Heederik1, Lidwien A M Smit1, Heike Schmitt1.
Abstract
OBJECTIVES: To determine associations between farm- and flock-level antimicrobial usage (AMU), farm biosecurity status and the abundance of faecal antimicrobial resistance genes (ARGs) on broiler farms.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31199864 PMCID: PMC6916135 DOI: 10.1093/jac/dkz235
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790
General characteristics of the sampled farms and flocks by country and overall countries
| Country | Number of farms included in the analyses | Average number of broilers present at the farm | Average number of rounds per year | Number of broilers set up in the sampled barn | Age of broilers during sampling (days) | Average weight of broilers during sampling (g) | Average weight of broilers at slaughter (g) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| mean | median | mean | median | mean | median | mean | median | mean | median | mean | median | ||
| (range) | (range) | (range) | (range) | (range) | (range) | ||||||||
| A | 20 | 77322 | 80000 | 7 | 7 | 29952 | 28300 | 34 | 35 | 2042 | 2125 | 2529 | 2500 |
| (24530–180000) | (3–8) | (16500–46700) | (27–39) | (1300–2490) | (2385–2750) | ||||||||
| B | 18 | 106059 | 76600 | 8 | 8 | 29827 | 32750 | 31 | 33 | 1861 | 1900 | 2320 | 2400 |
| (17200–240000) | (7.3–8.5) | (17200–41400) | (19–40) | (1350–2700) | (1550–2700) | ||||||||
| C | 20 | 46255 | 35150 | 8 | 8 | 35035 | 34450 | 26 | 27 | 1361 | 1322 | 2236 | 2193 |
| (25000–144000) | (7–8.5) | (25000–53300) | (16–32) | (530–2000) | (2000–2800) | ||||||||
| D | 20 | 96390 | 60000 | 5 | 5 | 23398 | 20950 | 42 | 43 | 2440 | 2450 | 2645 | 2600 |
| (24000–400000) | (4–5.5) | (11340–50000) | (34–51) | (1600–3650) | (2100–3700) | ||||||||
| E | 20 | 54810 | 47500 | 6 | 6 | 30605 | 29580 | 31 | 29 | 1479 | 1214 | 1744 | 1625 |
| (21400–216000) | (3–9) | (21420–42886) | (21–48) | (575–3000) | (1300–2700) | ||||||||
| F | 20 | 108258 | 110000 | 7 | 7 | 30849 | 31200 | 36 | 36 | 1939 | 1940 | 2375 | 2388 |
| (32000–200000) | (6–8.5) | (17550–49700) | (29–42) | (1500–2500) | (2065–2721) | ||||||||
| G | 20 | 56135 | 41500 | 6 | 6 | 31473 | 33565 | 36 | 36 | 2009 | 2070 | 2528 | 2500 |
| (19000–150000) | (5–6) | (18500–41800) | (30–42) | (1300–2500) | (2050–2900) | ||||||||
| H | 20 | 41680 | 30210 | 5 | 6 | 23219 | 22440 | 36 | 37 | 1907 | 1900 | 2693 | 2750 |
| (20000–114141) | (2–6.5) | (14000–33864) | (22–44) | (859–2500) | (1750–3000) | ||||||||
| I | 18 | 54873 | 20000 | 6 | 6 | 16413 | 16725 | 31 | 29 | 1529 | 1645 | 2264 | 2200 |
| (8000–250000) | (4–7) | (8000–27000) | (19–54) | (730–2600) | (1950–2700) | ||||||||
| Overall | 176 | 71101 | 50000 | 6.35 | 6.15 | 27971 | 26500 | 33.8 | 34 | 1844 | 1850 | 2372 | 2450 |
| (8000–400000) | (2–9) | (8000–53300) | (19–54) | (575–3650) | (1300–3700) | ||||||||
Figure 1.(a) Mean sum of ARGs in FPKM of farms that did or did not report AMU in group treatments for the sampled flock, grouped by country. Left: total ARGs versus total AMU per flock with number of farms shown above the bars. Right: ARGs of several (handpicked) antimicrobial classes/groups versus corresponding AMU per flock with number of farms shown above the bars. (b) Mean sum of ARGs in FPKM of farms that did or did not report AMU in purchased products by the whole farm in the year before sampling, grouped by country. Left: total ARGs versus total AMU per farm with number of farms shown above the bars. Right: ARGs of several (handpicked) antimicrobial classes/groups versus corresponding AMU per farm with number of farms shown above the bars.
Results of meta-analysis between ARGs in FPKM and AMU as TIDDDvet of corresponding antimicrobial classes/groups
| Class/group of ARGs | Class/group of AMU | Estimate |
| FDR | 95% CI | Country and number of farms with reported AMU |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sulphonamide | trimethoprim/sulphonamide (purchased) | 0.72 | 0.106 | 0.177 | −0.15–1.59 | A-11, B-9, C-1, D-16, E-7, F-16, G-9 |
| Total | total (group) | 0.33 | 0.207 | 0.319 | −0.18–0.85 | A-18, B-11, C-3, D-19, E-16, F-5, G-19, H-16, I-3 |
| Sulphonamide | trimethoprim/sulphonamide (group) | 0.47 | 0.238 | 0.340 | −0.31–1.26 | A-4, D-11, E-5, F-3, G-2 |
| Amphenicol | amphenicol (group) | 1.10 | 0.266 | 0.354 | −0.84–3.04 | G-1 |
| β-Lactam | β-lactam (purchased) | 0.30 | 0.298 | 0.373 | −0.26–0.86 | A-20, B-15, D-20, E-16, F-18, G-14, H-10, I-1 |
| Polymyxin | polymyxin (purchased) | −0.07 | 0.668 | 0.786 | −0.38–0.24 | B-14, D-18, E-7, F-2, G-11, H-4, I-1 |
| Quinolone | quinolone (purchased) | 0.20 | 0.738 | 0.820 | −0.96–1.36 | A-15, B-4, D-16, E-17, F-8, G-20, H-7, I-8 |
| Quinolone | quinolone (group) | −0.02 | 0.915 | 0.964 | −0.41–0.36 | A-7, B-1, D-6, E-10, F-1, G-16, H-7, I-2 |
| Polymyxin | polymyxin (group) | 0.00 | 0.987 | 0.987 | −0.35–0.35 | B-2, D-9, E-3, G-6, H-4 |
Associations in bold have a false discovery rate <0.1.
(group) indicates AMU in group treatments of the sampled flock; (purchased) indicates AMU in purchased products by the farm in the year before sampling.
Figure 2.Two example forest plots of the country-specific associations and meta-analysis results. Left: β-lactam ARGs in FPKM and β-lactam group treatments as TIDDDvet. Right: MLS ARGs (FPKM) and purchased MLS products (TIDDDvet). The number of farms that report AMU, the weight of the individual association in the summary estimate and the 95% CI per country are also shown. The summary estimates with confidence intervals for the overall association are shown at the bottom.
Ten most abundant gene clusters per antimicrobial class/group (which gave an overall significant association with AMU) and their contribution to the total sum of ARGs in percentages
| Rank | β-Lactam | % | MLS | % | Aminoglycoside | % | Tetracycline | % | Amphenicol | % | Trimethoprim | % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| 84.65 |
| 41.11 |
| 23.06 |
| 57.35 |
| 29.90 |
| 47.50 |
| 2 |
| 2.43 |
| 21.65 |
| 12.73 |
| 8.67 |
| 23.49 |
| 15.34 |
| 3 |
| 1.70 |
| 17.97 |
| 10.50 |
| 6.71 |
| 16.25 |
| 7.90 |
| 4 |
| 1.67 |
| 3.80 |
| 9.78 |
| 6.06 |
| 12.92 |
| 7.14 |
| 5 |
| 1.65 |
| 2.40 |
| 9.27 |
| 3.55 |
| 5.26 |
| 5.17 |
| 6 |
| 1.43 |
| 1.86 |
| 8.15 |
| 2.94 |
| 2.71 |
| 4.35 |
| 7 |
| 1.35 |
| 1.59 |
| 3.24 |
| 2.66 |
| 1.64 |
| 3.39 |
| 8 |
| 1.26 |
| 1.49 |
| 3.08 |
| 1.92 |
| 1.51 |
| 3.25 |
| 9 |
| 0.59 |
| 0.95 |
| 2.98 |
| 1.75 |
| 1.17 |
| 2.96 |
| 10 |
| 0.53 |
| 0.91 |
| 2.98 |
| 1.51 |
| 1.06 |
| 1.90 |